A detailed history of Us Bancorp \De\ transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,002 shares of FDMT stock, worth $5,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,002
Previous 1,104 9.24%
Holding current value
$5,821
Previous $23,000 56.52%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$10.81 - $27.22 $1,102 - $2,776
-102 Reduced 9.24%
1,002 $10,000
Q2 2024

Aug 06, 2024

SELL
$20.93 - $30.01 $15,823 - $22,687
-756 Reduced 40.65%
1,104 $23,000
Q1 2024

May 07, 2024

BUY
$17.03 - $35.87 $1,072 - $2,259
63 Added 3.51%
1,860 $59,000
Q4 2023

Feb 09, 2024

BUY
$9.76 - $21.25 $14,962 - $32,576
1,533 Added 580.68%
1,797 $36,000
Q2 2023

Aug 09, 2023

BUY
$15.16 - $23.26 $4,002 - $6,140
264 New
264 $4,000
Q4 2022

Feb 13, 2023

SELL
$6.85 - $25.46 $1,774 - $6,594
-259 Reduced 69.62%
113 $2,000
Q3 2022

Oct 27, 2022

SELL
$6.96 - $11.48 $2,449 - $4,040
-352 Reduced 48.62%
372 $3,000
Q2 2022

Aug 01, 2022

SELL
$5.68 - $15.99 $3,862 - $10,873
-680 Reduced 48.43%
724 $5,000
Q1 2022

May 11, 2022

BUY
$13.16 - $22.64 $9,146 - $15,734
695 Added 98.03%
1,404 $21,000
Q4 2021

Feb 11, 2022

BUY
$19.56 - $32.94 $7,647 - $12,879
391 Added 122.96%
709 $16,000
Q3 2021

Nov 10, 2021

BUY
$22.73 - $36.04 $6,773 - $10,739
298 Added 1490.0%
318 $9,000
Q2 2021

Aug 05, 2021

BUY
$22.2 - $42.29 $444 - $845
20 New
20 $0

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $188M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.